文献速递重症综合管理与镇静镇痛创伤与烧伤

创伤ICU患者阿片类与苯二氮䓬类戒断综合征:一项前瞻性探索性研究

Opioid and Benzodiazepine Withdrawal Syndromes in Trauma ICU Patients: A Prospective Exploratory Study.
PubMed 文献 · Crit Care Explor · 2020-04-29
一句话结论创伤ICU中接受阿片类和/或苯二氮䓬类≥5天的患者, probable戒断综合征发生率为44%,与机械通气时间延长和ICU及住院时间增加相关。

该前瞻性探索性观察研究在波多黎各一家大型医疗中心的创伤ICU进行,纳入50例接受阿片类和/或苯二氮䓬类≥5天的患者,使用基于成人ICU研究、DSM-5和ICD-10开发的戒断综合征检查表,在基线及药物减量开始后72小时内评估。 probable戒断综合征发生率为44%,可疑戒断综合征为20%,无戒断综合征为36%。 probable戒断综合征组更常见激越、腹泻、发热、呼吸急促、流泪和多动性谵妄,且机械通气时间几乎翻倍,ICU和住院时间均更高。年龄、累积阿片剂量及既往药物使用与戒断综合征风险相关;多水平分析加入RASS和谵妄后,高龄不再具有保护作用,而RASS评分升高、谵妄存在和机械通气时间延长与更高的戒断综合征风险相关。作者建议进一步验证该检查表。

要点

  • 创伤ICU中接受阿片类和/或苯二氮䓬类≥5天的患者, probable戒断综合征发生率为44%,可疑戒断综合征为20%。
  • probable戒断综合征组更常见激越、腹泻、发热、呼吸急促、流泪和多动性谵妄。
  • probable戒断综合征患者机械通气时间几乎翻倍,ICU和住院时间均高于其他两组。
  • 年龄、累积阿片剂量及既往药物(阿片类/苯二氮䓬类、大麻、可卡因或海洛因)使用与戒断综合征风险相关。
  • 多水平分析加入RASS和谵妄后,高龄不再具有保护作用,而RASS评分升高、谵妄和机械通气时间延长与更高戒断风险相关。

适用人群与场景

  • 创伤ICU中接受阿片类和/或苯二氮䓬类治疗≥5天的患者。

诊断标准与关键阈值

  • 使用基于成人ICU研究、DSM-5和ICD-10开发的阿片类/苯二氮䓬类戒断综合征检查表进行评估,在基线及药物减量开始后72小时内评估。
  • probable戒断综合征、可疑戒断综合征和无戒断综合征的分类由该检查表判定。

红旗征与不能漏的情况

  • probable戒断综合征组更常见的体征包括激越、腹泻、发热、呼吸急促、流泪和多动性谵妄。

研究设计与关键结果

  • 前瞻性探索性观察研究,纳入50例接受阿片类和/或苯二氮䓬类≥5天的创伤ICU患者。
  • 患者接受阿片类/苯二氮䓬类(88%)、阿片类(10%)或苯二氮䓬类(2%)。
  • probable戒断综合征发生率为44%,可疑戒断综合征为20%,无戒断综合征为36%。
  • probable戒断综合征组机械通气时间几乎翻倍,ICU和住院时间均高于其他两组。
  • 年龄、累积阿片剂量及既往药物(阿片类/苯二氮䓬类、大麻、可卡因或海洛因)使用与戒断综合征风险相关。
  • 多水平分析加入RASS和谵妄后,高龄不再具有保护作用,RASS评分升高、谵妄存在和机械通气时间延长与更高戒断综合征风险相关。

证据类型、等级与局限

  • 证据类型:前瞻性探索性观察研究。
  • 局限:作者建议进一步验证阿片类/苯二氮䓬类戒断综合征检查表。

对床旁实践的改变

  • 作者认为,在创伤ICU患者从阿片类和/或苯二氮䓬类减量过程中,应考虑本研究中发现的与戒断综合征显著相关的因素。
  • 作者建议进一步验证阿片类/苯二氮䓬类戒断综合征检查表。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Trauma ICU patients may require high and/or prolonged doses of opioids and/or benzodiazepines as part of their treatment. These medications may contribute to drug physical dependence, a response manifested by withdrawal syndrome. We aimed to identify risk factors, symptoms, and clinical variables associated with probable withdrawal syndrome.

DESIGN: Prospective exploratory observational study.

SETTING: Trauma ICU in large medical center in Puerto Rico.

PARTICIPANTS: Fifty patients who received opioids and/or benzodiazepines for greater than or equal to 5 days.

MEASUREMENTS AND MAIN RESULTS: Using an opioid/benzodiazepine withdrawal syndrome checklist developed from research in adult ICU patients, the Diagnostic and Statistical Manual of Mental Disorders-5, and the International Classification of Diseases, 10th Edition, we evaluated patients at baseline and for 72 hours after drug weaning was initiated. Patients received opioid/benzodiazepine (88%), opioid (10%), or benzodiazepine (2%). Probable withdrawal syndrome occurred in 44%, questionable withdrawal syndrome in 20%, and no withdrawal syndrome in 18 (36%). Signs that were more frequent in the probable withdrawal syndrome group were agitation, diarrhea, fever, tachypnea, lacrimation, and hyperactive delirium. Patients who developed probable withdrawal syndrome spent almost double the amount of time receiving mechanical ventilation, and length of stay was higher in both ICU and hospital when compared with patients in the other two groups. Age, cumulative opioid dose amounts, and previous drug (opioid/benzodiazepine, cannabis, cocaine, or heroin) use were associated with odds of developing withdrawal syndrome. With the addition of Richmond Agitation-Sedation Scale and delirium to the multilevel analysis, older age no longer had its protective effect, whereas increase in Richmond Agitation-Sedation Scale scores, delirium presence, and increased duration of mechanical ventilation were associated with higher odds of withdrawal syndrome.

CONCLUSIONS: We identified probable withdrawal syndrome in a sample of trauma ICU patients through observation of several associated symptoms. Significant factors associated with withdrawal syndrome found in this study should be considered when caring for patients being weaned from opioids and/or benzodiazepines. Further validation of the opioid/benzodiazepine withdrawal syndrome checklist is recommended.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Arroyo-Novoa CM, Figueroa-Ramos MI, Balas M, et al. Opioid and Benzodiazepine Withdrawal Syndromes in Trauma ICU Patients: A Prospective Exploratory Study. Crit Care Explor. 2020. PMID: 32426731. doi:10.1097/CCE.0000000000000089

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。